Superstring Capital Management LP

Investment Portfolio & 13F Holdings Analysis

About

CIK: 0001931118

Type: FundHoldings: 34Value: $84.0MLatest: 2025Q1

SUPERSTRING CAPITAL MANAGEMENT LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 34 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "ORIC",
  "MDGL",
  "SWTX",
  "SVRA",
  "TVTX",
  "TSHA",
  "TERN",
  "SMMT",
  "TECX",
  "LEGN",
  "KYTX",
  "ZBIO",
  "TARA",
  null,
  "PFE",
  "RNA",
  "SDGR",
  "MLTX",
  "SLNO",
  "COGT",
  "ETNB",
  "URGN",
  "VRNA",
  "VSTM",
  "ZLAB",
  "PCVX",
  "BBIO",
  "CABA",
  "CAPR",
  "IPSC",
  "CRNX",
  "CPIX",
  "CYTK"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 34
Total Value: 84048298
Accession Number: 0001931118-25-000004
Form Type: 13F-HR
CIK: superstring-capital-management-lp
Manager Name: Superstring-Capital-Management-Lp

Data Enrichment

97% identified

33 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

34 positions • $84.0M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

Zai Lab Ltd

ZLAB|98887Q104

Shares:294.9K

Value:$10.7M

% of Portfolio:12.7% ($10.7M/$84.0M)

BridgeBio Pharma, Inc.

BBIO|10806X102

Shares:183.9K

Value:$6.4M

% of Portfolio:7.6% ($6.4M/$84.0M)

Verona Pharma plc

VRNA|925050106

Shares:96.8K

Value:$6.1M

% of Portfolio:7.3% ($6.1M/$84.0M)

Legend Biotech Corp

LEGN|52490G102

Shares:160.4K

Value:$5.4M

% of Portfolio:6.5% ($5.4M/$84.0M)

PFIZER INC

PFE|717081103

Shares:196.2K

Value:$5.0M

% of Portfolio:5.9% ($5.0M/$84.0M)

UroGen Pharma Ltd.

URGN|M96088105

Shares:423.6K

Value:$4.7M

% of Portfolio:5.6% ($4.7M/$84.0M)

Cogent Biosciences, Inc.

COGT|19240Q201

Shares:774.7K

Value:$4.6M

% of Portfolio:5.5% ($4.6M/$84.0M)

Oric Pharmaceuticals, Inc.

ORIC|68622P109

Shares:819.2K

Value:$4.6M

% of Portfolio:5.4% ($4.6M/$84.0M)

Travere Therapeutics, Inc.

TVTX|89422G107

Shares:237.5K

Value:$4.3M

% of Portfolio:5.1% ($4.3M/$84.0M)

Terns Pharmaceuticals, Inc.

TERN|880881107

Shares:1.4M

Value:$3.7M

% of Portfolio:4.5% ($3.7M/$84.0M)

CYTOKINETICS INC

CYTK|23282W605

Shares:73.0K

Value:$2.9M

% of Portfolio:3.5% ($2.9M/$84.0M)

Savara Inc

SVRA|805111101

Shares:966.2K

Value:$2.7M

% of Portfolio:3.2% ($2.7M/$84.0M)

Summit Therapeutics Inc.

SMMT|86627T108

Shares:132.0K

Value:$2.5M

% of Portfolio:3.0% ($2.5M/$84.0M)

SpringWorks Therapeutics, Inc.

SWTX|85205L107

Shares:54.2K

Value:$2.4M

% of Portfolio:2.8% ($2.4M/$84.0M)

CAPRICOR THERAPEUTICS, INC.

CAPR|14070B309

Shares:241.2K

Value:$2.3M

% of Portfolio:2.7% ($2.3M/$84.0M)

Verastem, Inc.

VSTM|92337C203

Shares:336.4K

Value:$2.0M

% of Portfolio:2.4% ($2.0M/$84.0M)

Protara Therapeutics, Inc.

TARA|74365U107

Shares:360.0K

Value:$1.5M

% of Portfolio:1.8% ($1.5M/$84.0M)

Crinetics Pharmaceuticals, Inc.

CRNX|22663K107

Shares:43.6K

Value:$1.5M

% of Portfolio:1.7% ($1.5M/$84.0M)

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:19.3K

Value:$1.4M

% of Portfolio:1.6% ($1.4M/$84.0M)

MADRIGAL PHARMACEUTICALS, INC.

MDGL|558868105

Shares:3.8K

Value:$1.3M

% of Portfolio:1.5% ($1.3M/$84.0M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Zai Lab Ltd(ZLABcusip98887Q104)	294.9K	QoQ -26.92% (-108.7K) YoY NEW(+294.9K)	All Managers (Combined)	$10.7M	12.7% ($10.7M/$84.0M)	QoQ +0.83% (-$88.3K) YoY NEW(+$10.7M)
BridgeBio Pharma, Inc.(BBIOcusip10806X102)	183.9K	QoQ -29.83% (-78.2K) YoY -47.97% (-169.6K)	All Managers (Combined)	$6.4M	7.6% ($6.4M/$84.0M)	QoQ -11.60% (-$835.0K) YoY -41.83% (-$4.6M)
Verona Pharma plc(VRNAcusip925050106)	96.8K	QoQ NEW(+96.8K) YoY -62.67% (-162.6K)	All Managers (Combined)	$6.1M	7.3% ($6.1M/$84.0M)	QoQ NEW(+$6.1M) YoY +47.29% (-$2.0M)
Legend Biotech Corp(LEGNcusip52490G102)	160.4K	QoQ +130.53% (+90.8K) YoY NEW(+160.4K)	All Managers (Combined)	$5.4M	6.5% ($5.4M/$84.0M)	QoQ +140.38% (+$3.2M) YoY NEW(+$5.4M)
PFIZER INC(PFEcusip717081103)	196.2K	QoQ NEW(+196.2K) YoY NEW(+196.2K)	All Managers (Combined)	$5.0M	5.9% ($5.0M/$84.0M)	QoQ NEW(+$5.0M) YoY NEW(+$5.0M)
UroGen Pharma Ltd.(URGNcusipM96088105)	423.6K	QoQ +40.64% (+122.4K) YoY +46.95% (+135.4K)	All Managers (Combined)	$4.7M	5.6% ($4.7M/$84.0M)	QoQ +46.05% (+$1.5M) YoY +8.35% (+$361.4K)
Cogent Biosciences, Inc.(COGTcusip19240Q201)	774.7K	QoQ -14.94% (-136.1K) YoY NEW(+774.7K)	All Managers (Combined)	$4.6M	5.5% ($4.6M/$84.0M)	QoQ -34.68% (-$2.5M) YoY NEW(+$4.6M)
Oric Pharmaceuticals, Inc.(ORICcusip68622P109)	819.2K	QoQ -48.17% (-761.6K) YoY NEW(+819.2K)	All Managers (Combined)	$4.6M	5.4% ($4.6M/$84.0M)	QoQ -64.16% (-$8.2M) YoY NEW(+$4.6M)
Travere Therapeutics, Inc.(TVTXcusip89422G107)	237.5K	QoQ NEW(+237.5K) YoY NEW(+237.5K)	All Managers (Combined)	$4.3M	5.1% ($4.3M/$84.0M)	QoQ NEW(+$4.3M) YoY NEW(+$4.3M)
Terns Pharmaceuticals, Inc.(TERNcusip880881107)	1.4M	QoQ -32.83% (-663.4K) YoY NEW(+1.4M)	All Managers (Combined)	$3.7M	4.5% ($3.7M/$84.0M)	QoQ -66.53% (-$7.4M) YoY NEW(+$3.7M)
CYTOKINETICS INC(CYTKcusip23282W605)	73.0K	QoQ -43.58% (-56.4K) YoY -73.83% (-205.9K)	All Managers (Combined)	$2.9M	3.5% ($2.9M/$84.0M)	QoQ -51.80% (-$3.2M) YoY -84.99% (-$16.6M)
Savara Inc(SVRAcusip805111101)	966.2K	QoQ +90.07% (+457.9K) YoY -53.21% (-1.1M)	All Managers (Combined)	$2.7M	3.2% ($2.7M/$84.0M)	QoQ +71.49% (+$1.1M) YoY -73.97% (-$7.6M)
Summit Therapeutics Inc.(SMMTcusip86627T108)	132.0K	QoQ -19.77% (-32.5K) YoY NEW(+132.0K)	All Managers (Combined)	$2.5M	3.0% ($2.5M/$84.0M)	QoQ -13.28% (-$390.0K) YoY NEW(+$2.5M)
SpringWorks Therapeutics, Inc.(SWTXcusip85205L107)	54.2K	QoQ NEW(+54.2K) YoY NEW(+54.2K)	All Managers (Combined)	$2.4M	2.8% ($2.4M/$84.0M)	QoQ NEW(+$2.4M) YoY NEW(+$2.4M)
CAPRICOR THERAPEUTICS, INC.(CAPRcusip14070B309)	241.2K	QoQ +336.71% (+186.0K) YoY NEW(+241.2K)	All Managers (Combined)	$2.3M	2.7% ($2.3M/$84.0M)	QoQ +200.31% (+$1.5M) YoY NEW(+$2.3M)
Verastem, Inc.(VSTMcusip92337C203)	336.4K	QoQ +60.25% (+126.5K) YoY NEW(+336.4K)	All Managers (Combined)	$2.0M	2.4% ($2.0M/$84.0M)	QoQ +86.91% (+$943.1K) YoY NEW(+$2.0M)
Protara Therapeutics, Inc.(TARAcusip74365U107)	360.0K	QoQ 0.00% (-0) YoY NEW(+360.0K)	All Managers (Combined)	$1.5M	1.8% ($1.5M/$84.0M)	QoQ -19.31% (-$367.2K) YoY NEW(+$1.5M)
Crinetics Pharmaceuticals, Inc.(CRNXcusip22663K107)	43.6K	QoQ NEW(+43.6K) YoY NEW(+43.6K)	All Managers (Combined)	$1.5M	1.7% ($1.5M/$84.0M)	QoQ NEW(+$1.5M) YoY NEW(+$1.5M)
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	19.3K	QoQ NEW(+19.3K) YoY NEW(+19.3K)	All Managers (Combined)	$1.4M	1.6% ($1.4M/$84.0M)	QoQ NEW(+$1.4M) YoY NEW(+$1.4M)
MADRIGAL PHARMACEUTICALS, INC.(MDGLcusip558868105)	3.8K	QoQ +237.90% (+2.7K) YoY NEW(+3.8K)	All Managers (Combined)	$1.3M	1.5% ($1.3M/$84.0M)	QoQ +262.72% (+$915.3K) YoY NEW(+$1.3M)